# Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)

> **NCT00982137** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 108 (actual)

## Conditions studied

- Japanese Encephalitis
- Yellow Fever

## Interventions

- **BIOLOGICAL:** Live attenuated Japanese encephalitis virus; Yellow fever virus
- **BIOLOGICAL:** Yellow fever virus; Live attenuated Japanese encephalitis virus
- **BIOLOGICAL:** Live attenuated Japanese encephalitis virus; Yellow fever virus
- **BIOLOGICAL:** Live attenuated Japanese encephalitis virus; Yellow fever virus

## Key facts

- **NCT ID:** NCT00982137
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2005-04
- **Final completion:** 2007-03
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2012-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982137, "Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00982137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*